All Community pharmacist articles
-
NewsAnalgesics are commonly prescribed for inflammatory arthritis despite little benefit
Patients with inflammatory arthritis continue to be routinely prescribed analgesics in primary care, despite limited evidence of their effectiveness
-
News
Community pharmacists pitch in to help tackle obesity
High street pharmacists have been enlisted to help fight the battle against rising numbers of people who are obese
-
News
An estimated 1.2 million deaths from antibiotic-resistant infections in 2019
The first global assessment of deaths from antibiotic-resistant infections has revealed the scale and impact of antimicrobial resistance across the world
-
News
Richard Meddings CBE appointed as the new Chair of NHS England
Mr Meddings will begin the 4-year role in March 2022, and will focus on the health service’s recovery from the pandemic and workforce expansion
-
News
Community pharmacy shouldering the burden of COVID testing oversight
Leyla Hannbeck urges the Government to engage more thoroughly with community pharmacy on public health strategy, to avoid future scenarios similar to the recent lateral flow device shortage
-
News
Happy New Year to community pharmacy
Sophie Hatton introduces readers to the January 2022 edition of Guidelines for Pharmacy
-
News
Growing gap between life expectancy and healthy working life expectancy raises challenges for pensions
A recent study has shown that, although average lifespan has increased, the period that older people spend in good health and able to work has not necessarily extended at the same rate
-
News
NICE aims to have greater flexibility in its evaluation of new health technologies
Changes come into effect from next month to the way medicines and other health technologies are evaluated by NICE for use in the NHS
-
PHE/DH/DWP guideline
UKHSA management of staff exposure to COVID-19
This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results
-
News
Poor memory and attention persists months after mild COVID-19 recovery
Even those who had mild COVID-19 infection and don’t report having post-COVID problems are affected by cognitive impairment, researchers suggest
-
News
Sharp rise in meningococcal disease among students
The return of students to university and colleges, and the lifting of COVID-19 restrictions, was accompanied by a substantial increase in MenB cases in England
-
News
Lateral flow tests’ performance varies broadly, falling short of WHO criteria
A University of Manchester study has highlighted the inconsistent and insufficient sensitivity of lateral flow tests for identifying people with COVID-19
-
News
Airborne SARS-CoV-2 ‘could lose 90% of infectiousness after 20 minutes’
A study found infectivity of the airborne virus fell to around 10%, 20 minutes after being exhaled, with most of the decline taking place in the first 5 minutes
-
News
COVID-19-related perinatal and maternal outcomes worse in unvaccinated women
Pregnant women who contract SARS-CoV-2 within 28 days of their delivery date are at increased risk of perinatal and maternal complications
-
News
BMA: NHS strategy to terminate staff without vaccinations risks making staff shortages worse
The professional body has called the strategy of COVID-19 vaccination as a condition of demployment for NHS healthcare workers ‘very worrying’
-
News
Psychological distress is associated with a greater risk of COVID-19 infection
Stress, anxiety, and depression are not only consequences of living with the pandemic, but may also be factors that increase our risk of contracting COVID-19
-
PHE/DH/DWP guideline
UKHSA IPC for seasonal respiratory infections guideline
Covering the infection prevention and control principles required to prevent transmission of COVID-19 and other respiratory viruses for winter 2021–2022
-
News
WHO recommends two new drugs to treat COVID-19
In updated guidance on therapeutics for COVID-19, the World Health Organization has added recommendations on two new drugs to treat the disease
-
News
One in three still infectious after 5-day COVID-19 quarantine
Potentially active coronavirus may persist beyond 10 days, facilitating onward transmission of COVID-19 after a person has completed the advised quarantine period
-
Supplement
Improving patient outcomes: supporting pharmacists with the management of pancreatic exocrine insufficiency (PEI)
This supplement has been commissioned, funded, and reviewed by Viatris and developed in partnership with Guidelines for Pharmacy.
Information intended for UK healthcare professionals only.
NON-2021-6348 January 2022
